Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)

ClinicalTrials.gov ID: NCT00105469

Public ClinicalTrials.gov record NCT00105469. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate the Clinical and Microbial Efficacy and Safety of 1.0% AzaSite Compared to 0.3% Tobramycin Ophthalmic Solution in the Treatment of Bacterial Conjunctivitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the clinical and microbial efficacy and safety of AzaSite compared to tobramycin for bacterial conjunctivitis. Adults and children one year of age and older with bacterial conjunctivitis in at least one eye are eligible. Subjects will be randomly assigned to the AzaSite group or Tobramycin group. Three visits will be required for the study.

Study identification

NCT ID
NCT00105469
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
743 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
1 Year and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2004 (Type not available)
Primary completion
Oct 2005 (Actual)
Completion
Oct 2005 (Actual)
Last update posted
Dec 16, 2013

2004 – 2005

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
Renaissance Center Birmingham Alabama 35205 —
Children's Eye Physicians Littleton Colorado 80122 —
Palm Beach Eye Associates Atlantis Florida 33462 —
The Eye Associates Bradenton Florida 34209 —
Alan Shuster, MD Jupiter Florida 33458 —
Pasco Eye Institute New Port Richey Florida 34652 —
Tukoi Institute for Clinical Research North Miami Beach Florida 33169 —
Advanced Eye Care Panama City Florida 32405 —
Presidential Eye Center West Palm Beach Florida 33401 —
Jon Fishburn, MD Boise Idaho 83706 —
Medisphere Medical Research Center, LLC Evansville Indiana 47714 —
Hutchinson Clinic Hutchinson Kansas 67502 —
Massachusetts Eye and Ear Infirmary Boston Massachusetts 02114 —
Mason Eye Institute Columbia Missouri 65212 —
Ophthalmology Associates Creve Coeur Missouri 63141 —
Research Eye Care Center Kansas City Missouri 64132 —
Ophthalmology Associates Princeton New Jersey 08540 —
Huntington Medical Group Huntington Station New York 11746 —
Cornerstone Eye Care High Point North Carolina 27262 —
Eye Health Northwest Portland Oregon 97209 —
Irving Weinberger, MD Pittsburgh Pennsylvania 15228 —
Southern Eye Associates, PA Greenville South Carolina 29605 —
Corona Research Consultants, Inc. El Paso Texas 79904 —
Cottonwood Ophthalmology Associates Murray Utah 84107 —
Rockwood Clinic, PS-Eye Center Spokane Washington 99205 —
Wenatchee Valley Medical Center Wenatchee Washington 98801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00105469, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 16, 2013 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00105469 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →